RNAC
Cartesian Therapeutics Inc.
Latest News for RNAC
Analysts fell to the sidelines weighing in on Cartesian Therapeutics (RNAC – Research Report) and Galmed Pharmaceuticals (GLMD – Research Report) w......
In a report released today, Martin Fan from Wedbush maintained a Buy rating on Cartesian Therapeutics, with a price target of $38.00. Fan covers th......
In a report released yesterday, Kristen Kluska from Cantor Fitzgerald maintained a Hold rating on Cartesian Therapeutics, with a price target of $1......
Mizuho Securities analyst Uy Ear reiterated a Buy rating on Cartesian Therapeutics yesterday and set a price target of $40.00. Ear covers the Healt......
News data is sourced from MarketXLS API and updated regularly.
Showing 4 of 4 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RNAC | $7.24 | +1.3% | 127.39K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cartesian Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW